Molecular and cellular imaging by magnetic resonance(MR) provides real time in vivo analyses of the physiological, cellular, and molecular processes that occur in living tissues and their responses to medical interventions. New imaging techniques can monitor changes in tumor volume, tumor vascular permeability, cell-specific biochemical markers, protein expression, intratumoral drug concentrations and metabolism, and cell recruitment. The purpose of the newly proposed MRI Facility is to provide state of the art MR imaging (MRI) of both small animals and cancer patients, to support research activities of UPCI members.
The specific aims of the Facility are: (1) Provide comprehensive state of the art MRI methods, to support both basic and clinical scientific efforts in an economic and comprehensive fashion. These services include molecular and cellular imaging techniques, by supplying pulse sequence design and implementation, imaging protocol development, contrast agent synthesis, and data analyses package development services; (2) To provide consultation by the appropriate experts in the design and application of relevant MRI methods, so that UPCI members can knowledgeably choose the most suitable technique for their research; (3) To provide access to the appropriate instrumentation and the technical, physical, and intellectual skills to carry out these techniques, so that UPCI members will be able to utilize efficient and cutting edge imaging methods in a convenient and economical fashion, including pulse sequence design and implementation, imaging protocol development, contrast agent syntheses, and data analyses package development. During the past year, UPCI has recruited two new faculty members with expertise in cancer imaging, and in parallel, in recent years both the University of Pittsburgh and Carnegie Mellon University, working closely together, have invested heavily in both small animal and human MRI fystems. The funds requested for this new Facility will provide partial support for individuals with the technical expertise, purchase of supplies, and provide imaging time, so that UPCI investigators can use in vivo molecular and cellular methods to gain new and noninvasive insights into the physiology, biology, and biochemistry of cancer, at a minimal cost, which are expected to lead to advances in the accurate diagnosis of primary and metastatic tumors, and the assessment of responses to therapy for cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA047904-17
Application #
6989548
Study Section
Subcommittee G - Education (NCI)
Project Start
2004-09-22
Project End
2009-07-31
Budget Start
2004-09-22
Budget End
2005-07-31
Support Year
17
Fiscal Year
2004
Total Cost
$66,018
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Yockey, Laura J; Jurado, Kellie A; Arora, Nitin et al. (2018) Type I interferons instigate fetal demise after Zika virus infection. Sci Immunol 3:
Chen, Jingci; Nagle, Alison M; Wang, Yu-Fen et al. (2018) Controlled dimerization of insulin-like growth factor-1 and insulin receptors reveals shared and distinct activities of holo and hybrid receptors. J Biol Chem 293:3700-3709
Qin, Ye; Vasilatos, Shauna N; Chen, Lin et al. (2018) Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade. Oncogene :
Steinman, Justin; Epperly, Michael; Hou, Wen et al. (2018) Improved Total-Body Irradiation Survival by Delivery of Two Radiation Mitigators that Target Distinct Cell Death Pathways. Radiat Res 189:68-83
Evdokimova, Viktoria N; Gandhi, Manoj; Nikitski, Alyaksandr V et al. (2018) Nuclear myosin/actin-motored contact between homologous chromosomes is initiated by ATM kinase and homology-directed repair proteins at double-strand DNA breaks to suppress chromosome rearrangements. Oncotarget 9:13612-13622
Bissel, Stephanie J; Gurnsey, Kate; Jedema, Hank P et al. (2018) Aged Chinese-origin rhesus macaques infected with SIV develop marked viremia in absence of clinical disease, inflammation or cognitive impairment. Retrovirology 15:17
Knickelbein, Kyle; Tong, Jingshan; Chen, Dongshi et al. (2018) Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer. Oncogene 37:4599-4610
Diaz-Perez, Julio A; Killeen, Meaghan E; Yang, Yin et al. (2018) Extracellular ATP and IL-23 Form a Local Inflammatory Circuit Leading to the Development of a Neutrophil-Dependent Psoriasiform Dermatitis. J Invest Dermatol 138:2595-2605
Ancevski Hunter, Katerina; Socinski, Mark A; Villaruz, Liza C (2018) PD-L1 Testing in Guiding Patient Selection for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer. Mol Diagn Ther 22:1-10
Luu, Thehang; Kim, Kyu-Pyo; Blanchard, Suzette et al. (2018) Phase IB trial of ixabepilone and vorinostat in metastatic breast cancer. Breast Cancer Res Treat 167:469-478

Showing the most recent 10 out of 1187 publications